Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
12.42
0.00 (0.00%)
At close: May 22, 2026, 4:00 PM EDT
12.36
-0.06 (-0.50%)
After-hours: May 22, 2026, 7:40 PM EDT
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $3.96 billion as of May 22, 2026. Its market cap has increased by 69.47% in one year.
Market Cap
3.96B
Enterprise Value
6.46B
1-Year Change
69.47%
Ranking
Category
Stock Price
$12.42
Market Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has decreased from $5.76B to $3.96B, a decrease of -31.22%. That is a compound annual growth rate of -4.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 3.96B | 0.03% |
| Dec 31, 2025 | 3.96B | 61.41% |
| Dec 31, 2024 | 2.45B | 31.89% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
| Mar 27, 2018 | 5.76B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantheus Holdings | 6.71B |
| Alkermes | 6.13B |
| Hims & Hers Health | 5.50B |
| Liquidia | 5.42B |
| Kiniksa Pharmaceuticals International, | 4.10B |
| Supernus Pharmaceuticals | 2.80B |
| Prestige Consumer Healthcare | 2.27B |
| BioCryst Pharmaceuticals | 2.11B |